NCT00546052View on ClinicalTrials.gov

A 52 Week Study to Evaluate the Effects of Losartan With or Without HCTZ on Plasma Glucose, Metabolic Parameters, Blood Pressure in Hypertensive Patients With Metabolic Syndrome (0954A-331)

PHASE3CompletedINTERVENTIONAL

Enrollment

1,738

Participants

Timeline

Start Date

September 1, 2005

Primary Completion Date

January 1, 2008

Study Completion Date

January 1, 2008

Conditions

HypertensionMetabolic Disorder

Interventions

DRUG

losartan potassium (+) hydrochlorothiazide

All patients received Losartan 50mg at Visit 2 titrated to Losartan 100mg (if target BP not achieved) titrated to Losartan 100mg + HCTZ 12.5mg (if necessary) up to Losartan 100mg + HCTZ 25mg. Duration of treatment was one year.

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00546052 - A 52 Week Study to Evaluate the Effects of Losartan With or Without HCTZ on Plasma Glucose, Metabolic Parameters, Blood Pressure in Hypertensive Patients With Metabolic Syndrome (0954A-331) | Biotech Hunter | Biotech Hunter